Randal J Kirk - Net Worth and Insider Trading
Randal J Kirk Net Worth
The estimated net worth of Randal J Kirk is at least $969 Million dollars as of 2024-04-27. Randal J Kirk is the 10% Owner of Halozyme Therapeutics Inc and owns about 14,092,771 shares of Halozyme Therapeutics Inc (HALO) stock worth over $544 Million. Randal J Kirk is the 10% Owner of Translate Bio Inc and owns about 7,550,669 shares of Translate Bio Inc (TBIO) stock worth over $282 Million. Randal J Kirk is also the Director, 10% Owner of Precigen Inc and owns about 96,757,351 shares of Precigen Inc (PGEN) stock worth over $136 Million. Besides these, Randal J Kirk also holds Fibrocell Science Inc (FCSC) , Alaunos Therapeutics Inc (TCRT) , AquaBounty Technologies Inc (AQB) , Ocugen Inc (OCGN) , Armata Pharmaceuticals Inc (ARMP) , Precipio Inc (PRPO) , Oragenics Inc (OGEN) , Soligenix Inc (SNGX) , Theriva Biologics Inc (TOVX) . Details can be seen in Randal J Kirk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randal J Kirk has not made any transactions after 2023-12-28 and currently still holds the listed stock(s).
Transaction Summary of Randal J Kirk
Randal J Kirk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randal J Kirk owns 11 companies in total, including Precigen Inc (PGEN) , AquaBounty Technologies Inc (AQB) , and Fibrocell Science Inc (FCSC) among others .
Click here to see the complete history of Randal J Kirk’s form 4 insider trades.
Insider Ownership Summary of Randal J Kirk
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PGEN | Precigen Inc | 2023-12-28 | director & 10 percent owner & Chief Executive Officer |
AQB | AquaBounty Technologies Inc | 2021-11-23 | 10 percent owner |
FCSC | Fibrocell Science Inc | 2019-12-13 | 10 percent owner |
TOVX | Theriva Biologics Inc | 2019-04-03 | 10 percent owner |
OCGN | Ocugen Inc | 2019-01-15 | 10 percent owner |
TCRT | Alaunos Therapeutics Inc | 2013-10-29 | director |
PRPO | Precipio Inc | 2018-08-28 | 10 percent owner |
HALO | Halozyme Therapeutics Inc | 2018-08-28 | 10 percent owner |
SNGX | Soligenix Inc | 2017-05-08 | 10 percent owner |
ARMP | Armata Pharmaceuticals Inc | 2016-12-29 | 10 percent owner |
OGEN | Oragenics Inc | 2016-06-30 | 10 percent owner |
Randal J Kirk Latest Holdings Summary
Randal J Kirk currently owns a total of 12 stocks. Among these stocks, Randal J Kirk owns 14,092,771 shares of Halozyme Therapeutics Inc (HALO) as of August 28, 2018, with a value of $544 Million and a weighting of 56.08%. Randal J Kirk owns 7,550,669 shares of Translate Bio Inc (TBIO) as of January 6, 2016, with a value of $282 Million and a weighting of 29.1%. Randal J Kirk also owns 96,757,351 shares of Precigen Inc (PGEN) as of December 28, 2023, with a value of $136 Million and a weighting of 14.08%. The other 9 stocks Fibrocell Science Inc (FCSC) , Alaunos Therapeutics Inc (TCRT) , AquaBounty Technologies Inc (AQB) , Ocugen Inc (OCGN) , Armata Pharmaceuticals Inc (ARMP) , Precipio Inc (PRPO) , Oragenics Inc (OGEN) , Soligenix Inc (SNGX) , Theriva Biologics Inc (TOVX) have a combined weighting of 0.74% among all his current holdings.
Latest Holdings of Randal J Kirk
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2018-08-28 | 14,092,771 | 38.57 | 543,558,177 |
TBIO | Translate Bio Inc | 2016-01-06 | 7,550,669 | 37.36 | 282,092,994 |
PGEN | Precigen Inc | 2023-12-28 | 96,757,351 | 1.41 | 136,427,865 |
FCSC | Fibrocell Science Inc | 2017-12-11 | 1,653,483 | 3.00 | 4,960,449 |
TCRT | Alaunos Therapeutics Inc | 2013-10-29 | 1,186,460 | 1.32 | 1,566,127 |
AQB | AquaBounty Technologies Inc | 2021-11-23 | 266,991 | 1.95 | 520,632 |
OCGN | Ocugen Inc | 2019-01-15 | 28,207 | 1.28 | 36,105 |
ARMP | Armata Pharmaceuticals Inc | 2016-12-29 | 10,074 | 2.76 | 27,804 |
PRPO | Precipio Inc | 2018-08-28 | 4,448 | 6.03 | 26,799 |
OGEN | Oragenics Inc | 2016-06-30 | 25,803 | 1.03 | 26,577 |
SNGX | Soligenix Inc | 2017-05-08 | 35,054 | 0.42 | 14,547 |
TOVX | Theriva Biologics Inc | 2019-04-03 | 22,767 | 0.42 | 9,551 |
Holding Weightings of Randal J Kirk
Randal J Kirk Form 4 Trading Tracker
According to the SEC Form 4 filings, Randal J Kirk has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the sale of 644,998 shares on August 28, 2018, which brought Randal J Kirk around $12 Million.
According to the SEC Form 4 filings, Randal J Kirk has made a total of 0 transactions in Translate Bio Inc (TBIO) over the past 5 years. The most-recent trade in Translate Bio Inc is the acquisition of 4,474,825 shares on January 6, 2016, which cost Randal J Kirk around $4 Million.
According to the SEC Form 4 filings, Randal J Kirk has made a total of 19 transactions in Precigen Inc (PGEN) over the past 5 years, including 19 buys and 0 sells. The most-recent trade in Precigen Inc is the acquisition of 96,686 shares on December 28, 2023, which cost Randal J Kirk around $136,327.
More details on Randal J Kirk's insider transactions can be found in the Insider Trading History of Randal J Kirk table.Insider Trading History of Randal J Kirk
- 1
Randal J Kirk Trading Performance
GuruFocus tracks the stock performance after each of Randal J Kirk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randal J Kirk is 9.37%. GuruFocus also compares Randal J Kirk's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randal J Kirk within 3 months outperforms 40 times out of 71 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randal J Kirk's insider trading performs compared to the benchmark.
Performance of Randal J Kirk
Average Return
-3.39%
Outperforming Transactions
28%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 14.92 | 9.37 | 3.47 | -3.39 | -3.74 | -17.93 |
Relative Return to S&P 500(%) | 13.51 | 6.77 | -0.26 | -9.67 | -13.2 | -27.02 |
Randal J Kirk Ownership Network
Ownership Network List of Randal J Kirk
Ownership Network Relation of Randal J Kirk
Randal J Kirk Owned Company Details
What does Precigen Inc do?
Who are the key executives at Precigen Inc?
Randal J Kirk is the director & 10 percent owner & Chief Executive Officer of Precigen Inc. Other key executives at Precigen Inc include director & President and CEO Helen Sabzevari , Chief Operating Officer Rutul R Shah , and Chief Financial Officer Harry Jr. Thomasian .
Precigen Inc (PGEN) Insider Trades Summary
Over the past 18 months, Randal J Kirk made 3 insider transaction in Precigen Inc (PGEN) with a net purchase of 12,025,257. Other recent insider transactions involving Precigen Inc (PGEN) include a net sale of 204,273 shares made by Helen Sabzevari , a net sale of 12,301 shares made by Rutul R Shah , and a net sale of 6,806 shares made by Jeffrey Thomas Perez .
In summary, during the past 3 months, insiders sold 0 shares of Precigen Inc (PGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 455,706 shares of Precigen Inc (PGEN) were sold and 13,109,743 shares were bought by its insiders, resulting in a net purchase of 12,654,037 shares.
Precigen Inc (PGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Precigen Inc Insider Transactions
Randal J Kirk Mailing Address
Above is the net worth, insider trading, and ownership report for Randal J Kirk. You might contact Randal J Kirk via mailing address: 1881 Grove Avenue, Radford Va 24141.